

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 7.57064370 |
| 2 | DNA deamination (GO:0045006) | 7.29655440 |
| 3 | negative regulation of phagocytosis (GO:0050765) | 7.01507915 |
| 4 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.45949434 |
| 5 | innate immune response in mucosa (GO:0002227) | 6.38991918 |
| 6 | regulation of MHC class II biosynthetic process (GO:0045346) | 6.26602944 |
| 7 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.86073547 |
| 8 | microglial cell activation (GO:0001774) | 5.81463790 |
| 9 | antibacterial humoral response (GO:0019731) | 5.74310697 |
| 10 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 5.67369514 |
| 11 | response to peptidoglycan (GO:0032494) | 5.66993611 |
| 12 | negative regulation of interleukin-8 production (GO:0032717) | 5.65621417 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 5.40123704 |
| 14 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.31177486 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.28074558 |
| 16 | antimicrobial humoral response (GO:0019730) | 5.27220041 |
| 17 | DNA strand elongation (GO:0022616) | 5.06533615 |
| 18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.01090145 |
| 19 | mucosal immune response (GO:0002385) | 5.00414225 |
| 20 | pentose-phosphate shunt (GO:0006098) | 4.94730717 |
| 21 | * negative regulation of growth of symbiont in host (GO:0044130) | 4.90393736 |
| 22 | * negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.90393736 |
| 23 | * modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.90393736 |
| 24 | * regulation of growth of symbiont in host (GO:0044126) | 4.90393736 |
| 25 | * disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.90087012 |
| 26 | * killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.90087012 |
| 27 | cellular response to zinc ion (GO:0071294) | 4.86201808 |
| 28 | organ or tissue specific immune response (GO:0002251) | 4.84879899 |
| 29 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.78815089 |
| 30 | respiratory burst (GO:0045730) | 4.77598649 |
| 31 | * neutrophil mediated immunity (GO:0002446) | 4.69383961 |
| 32 | cell wall macromolecule catabolic process (GO:0016998) | 4.69214775 |
| 33 | reactive oxygen species biosynthetic process (GO:1903409) | 4.66749594 |
| 34 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.59863422 |
| 35 | NADPH regeneration (GO:0006740) | 4.58648417 |
| 36 | * response to fungus (GO:0009620) | 4.53005218 |
| 37 | cotranslational protein targeting to membrane (GO:0006613) | 4.49144187 |
| 38 | protein targeting to ER (GO:0045047) | 4.47020268 |
| 39 | viral transcription (GO:0019083) | 4.46007551 |
| 40 | DNA replication initiation (GO:0006270) | 4.45698127 |
| 41 | telomere maintenance via recombination (GO:0000722) | 4.42439621 |
| 42 | translational termination (GO:0006415) | 4.35663630 |
| 43 | protein localization to endoplasmic reticulum (GO:0070972) | 4.30198624 |
| 44 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.25575666 |
| 45 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.16403504 |
| 46 | hemoglobin metabolic process (GO:0020027) | 4.14309988 |
| 47 | DNA unwinding involved in DNA replication (GO:0006268) | 4.05459298 |
| 48 | * myeloid leukocyte mediated immunity (GO:0002444) | 4.03686772 |
| 49 | centriole replication (GO:0007099) | 4.01770174 |
| 50 | DNA replication checkpoint (GO:0000076) | 4.01238004 |
| 51 | IMP metabolic process (GO:0046040) | 3.96013171 |
| 52 | mitotic recombination (GO:0006312) | 3.95019940 |
| 53 | translational elongation (GO:0006414) | 3.91441550 |
| 54 | cell wall macromolecule metabolic process (GO:0044036) | 3.86677664 |
| 55 | * defense response to fungus (GO:0050832) | 3.83747661 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.82945148 |
| 57 | macrophage chemotaxis (GO:0048246) | 3.78239844 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.77490001 |
| 59 | pentose metabolic process (GO:0019321) | 3.77131066 |
| 60 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.76576896 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.75828226 |
| 62 | ribosomal small subunit biogenesis (GO:0042274) | 3.74606745 |
| 63 | glucose 6-phosphate metabolic process (GO:0051156) | 3.74325004 |
| 64 | telomere maintenance via telomere lengthening (GO:0010833) | 3.71271383 |
| 65 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.65758378 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.65758378 |
| 67 | nucleobase biosynthetic process (GO:0046112) | 3.62796074 |
| 68 | glial cell migration (GO:0008347) | 3.62682014 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.58736981 |
| 70 | ribosome assembly (GO:0042255) | 3.58579246 |
| 71 | * disruption of cells of other organism (GO:0044364) | 3.57516685 |
| 72 | * killing of cells of other organism (GO:0031640) | 3.57516685 |
| 73 | pseudouridine synthesis (GO:0001522) | 3.57211971 |
| 74 | macrophage activation (GO:0042116) | 3.52707392 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 3.48780194 |
| 76 | neutrophil activation (GO:0042119) | 3.46532002 |
| 77 | IMP biosynthetic process (GO:0006188) | 3.42332277 |
| 78 | maturation of SSU-rRNA (GO:0030490) | 3.41145582 |
| 79 | translational initiation (GO:0006413) | 3.38841771 |
| 80 | glucose catabolic process (GO:0006007) | 3.38601571 |
| 81 | cellular protein complex disassembly (GO:0043624) | 3.37107564 |
| 82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33937415 |
| 83 | defense response to Gram-positive bacterium (GO:0050830) | 3.31598511 |
| 84 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.31417537 |
| 85 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30493619 |
| 86 | induction of positive chemotaxis (GO:0050930) | 3.28949917 |
| 87 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.27970538 |
| 88 | viral life cycle (GO:0019058) | 3.24463496 |
| 89 | hydrogen peroxide metabolic process (GO:0042743) | 3.24435180 |
| 90 | regulation of phagocytosis (GO:0050764) | 3.23816997 |
| 91 | deoxyribose phosphate catabolic process (GO:0046386) | 3.18027060 |
| 92 | negative regulation of bone mineralization (GO:0030502) | 3.17905626 |
| 93 | signal peptide processing (GO:0006465) | 3.17707416 |
| 94 | hydrogen peroxide catabolic process (GO:0042744) | 3.15939437 |
| 95 | UV protection (GO:0009650) | 3.15802594 |
| 96 | deoxyribonucleotide catabolic process (GO:0009264) | 3.15675756 |
| 97 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.14501567 |
| 98 | macrophage differentiation (GO:0030225) | 3.13231074 |
| 99 | defense response to bacterium (GO:0042742) | 3.10352973 |
| 100 | regulation of cellular respiration (GO:0043457) | 3.08795060 |
| 101 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.06923151 |
| 102 | definitive hemopoiesis (GO:0060216) | 3.06544057 |
| 103 | neutrophil activation involved in immune response (GO:0002283) | 3.06440765 |
| 104 | secretory granule organization (GO:0033363) | 3.05479841 |
| 105 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.05463193 |
| 106 | centriole assembly (GO:0098534) | 3.04552585 |
| 107 | purine nucleobase biosynthetic process (GO:0009113) | 3.02505050 |
| 108 | fucose catabolic process (GO:0019317) | 3.01369889 |
| 109 | L-fucose metabolic process (GO:0042354) | 3.01369889 |
| 110 | L-fucose catabolic process (GO:0042355) | 3.01369889 |
| 111 | protein localization to kinetochore (GO:0034501) | 3.00806125 |
| 112 | granulocyte activation (GO:0036230) | 3.00259984 |
| 113 | translation (GO:0006412) | 3.00114629 |
| 114 | removal of superoxide radicals (GO:0019430) | 3.00033821 |
| 115 | cellular response to superoxide (GO:0071451) | 3.00033821 |
| 116 | cellular response to oxygen radical (GO:0071450) | 3.00033821 |
| 117 | positive regulation of histone deacetylation (GO:0031065) | 3.00020036 |
| 118 | mannose metabolic process (GO:0006013) | 2.98497883 |
| 119 | leukocyte degranulation (GO:0043299) | 2.96665037 |
| 120 | protein complex disassembly (GO:0043241) | 2.95571510 |
| 121 | anterograde synaptic vesicle transport (GO:0048490) | 2.95409944 |
| 122 | protein targeting to membrane (GO:0006612) | 2.94892497 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 2.94883896 |
| 124 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94163785 |
| 125 | negative regulation of RNA splicing (GO:0033119) | 2.92610963 |
| 126 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.91595292 |
| 127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.90260149 |
| 128 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.88991693 |
| 129 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.87668211 |
| 130 | natural killer cell activation involved in immune response (GO:0002323) | 2.86882232 |
| 131 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.86519239 |
| 132 | negative regulation of granulocyte differentiation (GO:0030853) | 2.85878764 |
| 133 | formation of translation preinitiation complex (GO:0001731) | 2.85314485 |
| 134 | ribosomal large subunit biogenesis (GO:0042273) | 2.85122684 |
| 135 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85058952 |
| 136 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.84168327 |
| 137 | leukotriene biosynthetic process (GO:0019370) | 2.83471430 |
| 138 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.82445826 |
| 139 | base-excision repair, AP site formation (GO:0006285) | 2.82366221 |
| 140 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.82080126 |
| 141 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.81514160 |
| 142 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77784184 |
| 143 | translesion synthesis (GO:0019985) | 2.77711910 |
| 144 | macromolecular complex disassembly (GO:0032984) | 2.77464547 |
| 145 | regulation of protein heterodimerization activity (GO:0043497) | 2.77096017 |
| 146 | angiogenesis involved in wound healing (GO:0060055) | 2.75962325 |
| 147 | heme biosynthetic process (GO:0006783) | 2.75421524 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.75282212 |
| 149 | * cell killing (GO:0001906) | 2.75243216 |
| 150 | negative regulation of biomineral tissue development (GO:0070168) | 2.73315584 |
| 151 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.72657014 |
| 152 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.72503309 |
| 153 | regulation of chemokine biosynthetic process (GO:0045073) | 2.72201093 |
| 154 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.70553037 |
| 155 | response to food (GO:0032094) | 2.70305199 |
| 156 | CENP-A containing nucleosome assembly (GO:0034080) | 2.70137782 |
| 157 | N-acetylneuraminate metabolic process (GO:0006054) | 2.69403608 |
| 158 | response to bacterium (GO:0009617) | 2.68381445 |
| 159 | rRNA processing (GO:0006364) | 2.67779710 |
| 160 | positive regulation of phagocytosis (GO:0050766) | 2.67352687 |
| 161 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67279815 |
| 162 | negative regulation of chemokine production (GO:0032682) | 2.66329286 |
| 163 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.66139927 |
| 164 | regulation of erythrocyte differentiation (GO:0045646) | 2.65387410 |
| 165 | purine nucleobase metabolic process (GO:0006144) | 2.64909245 |
| 166 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.64421703 |
| 167 | pinocytosis (GO:0006907) | 2.62032330 |
| 168 | chromatin remodeling at centromere (GO:0031055) | 2.61705033 |
| 169 | cellular extravasation (GO:0045123) | 10.4105897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.03435776 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.29143011 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.62318222 |
| 4 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.08242544 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.96973540 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.82409587 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.76936313 |
| 8 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.76869740 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.68780191 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.65906485 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.64357083 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.61422362 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.58228148 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.53350274 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.48222732 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.45536359 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40136801 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.35064818 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.33576411 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.33046110 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.28033073 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24092843 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15329535 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.10901872 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08846572 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.05358165 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.04879610 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.04004136 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.01807656 |
| 30 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.94623199 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94506879 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.93707911 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92135286 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91907899 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90921825 |
| 36 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.88188689 |
| 37 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84007980 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83094098 |
| 39 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.82712334 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82148306 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.81970424 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79996357 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.78080570 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.75939834 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.71005656 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68352353 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68274173 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68002969 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63001151 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.61580406 |
| 51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61025026 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59974986 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59761339 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.58033361 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56028465 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55114377 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53008349 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52368730 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50791525 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50287503 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46323616 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.45133020 |
| 63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.45089030 |
| 64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44635077 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44537317 |
| 66 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42716211 |
| 67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.42161256 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41727749 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41144431 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41125949 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39441951 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38711339 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38003624 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36883418 |
| 75 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36145357 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35099508 |
| 77 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.35016162 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34535882 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33894115 |
| 80 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31813294 |
| 81 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31776986 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29745408 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29345112 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27315686 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27139093 |
| 86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24463556 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24217943 |
| 88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24209372 |
| 89 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23776734 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 1.23729674 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23176723 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22832793 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21963777 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19019078 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18486115 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17693022 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17482777 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16710822 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16550445 |
| 100 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14811040 |
| 101 | MYB_26560356_Chip-Seq_TH1_Human | 1.12501684 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12097451 |
| 103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11963610 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11156948 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11049166 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09572502 |
| 107 | MAF_26560356_Chip-Seq_TH1_Human | 1.09182980 |
| 108 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08559278 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08496426 |
| 110 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05636438 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05010703 |
| 112 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04629677 |
| 113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04117643 |
| 114 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03762083 |
| 115 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.01601917 |
| 116 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00563030 |
| 117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00447118 |
| 118 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99549988 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98427969 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98179650 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98028585 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97512992 |
| 123 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95373966 |
| 124 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.95105688 |
| 125 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94552709 |
| 126 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.93458111 |
| 127 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93206341 |
| 128 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.93130425 |
| 129 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92932026 |
| 130 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92427814 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91394171 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90790596 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90631224 |
| 134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90375279 |
| 135 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90325527 |
| 136 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.90258443 |
| 137 | P68_20966046_ChIP-Seq_HELA_Human | 0.89863807 |
| 138 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89550256 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89008203 |
| 140 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88196355 |
| 141 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.87365328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 4.60105521 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.19738104 |
| 3 | MP0003693_abnormal_embryo_hatching | 4.01389226 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.58363961 |
| 5 | MP0003303_peritoneal_inflammation | 3.48404983 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.92654327 |
| 7 | MP0008057_abnormal_DNA_replication | 2.80361745 |
| 8 | MP0003436_decreased_susceptibility_to | 2.74665946 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.74605478 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.73476146 |
| 11 | MP0002419_abnormal_innate_immunity | 2.72664870 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.63237171 |
| 13 | MP0009278_abnormal_bone_marrow | 2.61745164 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.61163235 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.60296634 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.56265224 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.52839547 |
| 18 | MP0003724_increased_susceptibility_to | 2.46159068 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 2.45762005 |
| 20 | MP0003111_abnormal_nucleus_morphology | 2.45457846 |
| 21 | MP0000490_abnormal_crypts_of | 2.38709515 |
| 22 | MP0009785_altered_susceptibility_to | 2.27814449 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 2.26024722 |
| 24 | * MP0005025_abnormal_response_to | 2.24390446 |
| 25 | MP0003077_abnormal_cell_cycle | 2.22526065 |
| 26 | MP0008961_abnormal_basal_metabolism | 2.21683580 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.14696087 |
| 28 | MP0002009_preneoplasia | 2.13618858 |
| 29 | MP0008058_abnormal_DNA_repair | 2.07371338 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 2.05704580 |
| 31 | MP0005076_abnormal_cell_differentiation | 2.04947482 |
| 32 | MP0002006_tumorigenesis | 2.00623748 |
| 33 | MP0001853_heart_inflammation | 1.98483594 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.96766321 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.91535506 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.90888786 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.90888786 |
| 38 | MP0001819_abnormal_immune_cell | 1.87092703 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.86837530 |
| 40 | MP0000858_altered_metastatic_potential | 1.83718045 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.81451818 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.79207933 |
| 43 | * MP0002398_abnormal_bone_marrow | 1.72304925 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.69801201 |
| 45 | * MP0000716_abnormal_immune_system | 1.66027957 |
| 46 | MP0010307_abnormal_tumor_latency | 1.63956012 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.57628729 |
| 48 | * MP0002429_abnormal_blood_cell | 1.55645251 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.55385779 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.53672713 |
| 51 | MP0002723_abnormal_immune_serum | 1.53139679 |
| 52 | MP0005671_abnormal_response_to | 1.51960608 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.51804113 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.47983222 |
| 55 | * MP0002722_abnormal_immune_system | 1.46581579 |
| 56 | MP0006082_CNS_inflammation | 1.45793953 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.40298283 |
| 58 | * MP0000689_abnormal_spleen_morphology | 1.40096775 |
| 59 | MP0001800_abnormal_humoral_immune | 1.39466600 |
| 60 | MP0000685_abnormal_immune_system | 1.38585380 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.34126433 |
| 62 | MP0001873_stomach_inflammation | 1.34067667 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.32171057 |
| 64 | * MP0001845_abnormal_inflammatory_respons | 1.31321087 |
| 65 | MP0003828_pulmonary_edema | 1.31244036 |
| 66 | * MP0002019_abnormal_tumor_incidence | 1.30805103 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.29961864 |
| 68 | MP0002405_respiratory_system_inflammati | 1.27421772 |
| 69 | MP0003186_abnormal_redox_activity | 1.26638776 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.26306287 |
| 71 | MP0003866_abnormal_defecation | 1.22858684 |
| 72 | MP0004742_abnormal_vestibular_system | 1.19202555 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.18724866 |
| 74 | MP0005058_abnormal_lysosome_morphology | 1.17546657 |
| 75 | MP0001663_abnormal_digestive_system | 1.16971713 |
| 76 | MP0003252_abnormal_bile_duct | 1.16187822 |
| 77 | MP0006054_spinal_hemorrhage | 1.16040022 |
| 78 | MP0005360_urolithiasis | 1.15676483 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.12638493 |
| 80 | MP0000358_abnormal_cell_content/ | 1.10452036 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 1.09595382 |
| 82 | MP0008469_abnormal_protein_level | 1.09544130 |
| 83 | MP0000343_altered_response_to | 1.07367756 |
| 84 | MP0008873_increased_physiological_sensi | 1.06581470 |
| 85 | MP0005409_darkened_coat_color | 1.06058728 |
| 86 | MP0005670_abnormal_white_adipose | 1.05844246 |
| 87 | MP0008932_abnormal_embryonic_tissue | 1.01821680 |
| 88 | MP0000350_abnormal_cell_proliferation | 0.98608092 |
| 89 | MP0000313_abnormal_cell_death | 0.98014136 |
| 90 | MP0004381_abnormal_hair_follicle | 0.97801115 |
| 91 | MP0003646_muscle_fatigue | 0.97780783 |
| 92 | MP0009764_decreased_sensitivity_to | 0.97527594 |
| 93 | MP0005389_reproductive_system_phenotype | 0.96188438 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.96119112 |
| 95 | MP0001851_eye_inflammation | 0.95101316 |
| 96 | MP0002160_abnormal_reproductive_system | 0.95046454 |
| 97 | MP0005164_abnormal_response_to | 0.95034119 |
| 98 | MP0003786_premature_aging | 0.94623009 |
| 99 | MP0008995_early_reproductive_senescence | 0.92289652 |
| 100 | MP0004947_skin_inflammation | 0.90074522 |
| 101 | MP0001764_abnormal_homeostasis | 0.89626427 |
| 102 | MP0005408_hypopigmentation | 0.88017757 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.87329815 |
| 104 | MP0004147_increased_porphyrin_level | 0.86909742 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.85432172 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.84340587 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.83909449 |
| 108 | MP0005365_abnormal_bile_salt | 0.83234622 |
| 109 | MP0002970_abnormal_white_adipose | 0.82189266 |
| 110 | MP0005266_abnormal_metabolism | 0.81036406 |
| 111 | MP0009763_increased_sensitivity_to | 0.79109552 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.78457211 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.78318431 |
| 114 | MP0000249_abnormal_blood_vessel | 0.78316406 |
| 115 | MP0009115_abnormal_fat_cell | 0.77863868 |
| 116 | MP0000681_abnormal_thyroid_gland | 0.76683825 |
| 117 | * MP0000598_abnormal_liver_morphology | 0.76046984 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.75256262 |
| 119 | MP0001730_embryonic_growth_arrest | 0.74142579 |
| 120 | MP0009931_abnormal_skin_appearance | 0.73071965 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.71119692 |
| 122 | MP0005334_abnormal_fat_pad | 0.69940489 |
| 123 | MP0005387_immune_system_phenotype | 0.69813752 |
| 124 | MP0001790_abnormal_immune_system | 0.69813752 |
| 125 | MP0003075_altered_response_to | 0.69672021 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.67888467 |
| 127 | MP0002132_abnormal_respiratory_system | 0.66749198 |
| 128 | MP0002080_prenatal_lethality | 0.66513846 |
| 129 | MP0000371_diluted_coat_color | 0.66426357 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.65788631 |
| 131 | MP0003123_paternal_imprinting | 0.63004035 |
| 132 | MP0005384_cellular_phenotype | 0.62912850 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62684731 |
| 134 | MP0004264_abnormal_extraembryonic_tissu | 0.62599293 |
| 135 | MP0003448_altered_tumor_morphology | 0.61609305 |
| 136 | MP0002075_abnormal_coat/hair_pigmentati | 0.61176684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 6.90429663 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 5.44386165 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.01573756 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.95538481 |
| 5 | Abnormality of the prostate (HP:0008775) | 4.63059643 |
| 6 | Chronic obstructive pulmonary disease (HP:0006510) | 4.46317179 |
| 7 | Obstructive lung disease (HP:0006536) | 4.46317179 |
| 8 | Type I transferrin isoform profile (HP:0003642) | 4.43230355 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.38732145 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.34728067 |
| 11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.27265262 |
| 12 | Reticulocytopenia (HP:0001896) | 4.01384746 |
| 13 | Hypochromic microcytic anemia (HP:0004840) | 3.90269166 |
| 14 | Aplastic anemia (HP:0001915) | 3.89689779 |
| 15 | Amyloidosis (HP:0011034) | 3.86456332 |
| 16 | Acute lymphatic leukemia (HP:0006721) | 3.85195561 |
| 17 | Chest pain (HP:0100749) | 3.84582850 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.78688279 |
| 19 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.62607334 |
| 20 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.62607334 |
| 21 | Abnormal protein glycosylation (HP:0012346) | 3.62607334 |
| 22 | Abnormal glycosylation (HP:0012345) | 3.62607334 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.61042657 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.48086114 |
| 25 | Pulmonary fibrosis (HP:0002206) | 3.39291753 |
| 26 | Spondylolisthesis (HP:0003302) | 3.37344024 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.36812400 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31244663 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31244663 |
| 30 | Myositis (HP:0100614) | 3.30100336 |
| 31 | Hepatosplenomegaly (HP:0001433) | 3.25167326 |
| 32 | Ureteral stenosis (HP:0000071) | 3.22667896 |
| 33 | Chronic otitis media (HP:0000389) | 3.13597280 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06472416 |
| 35 | Periodontitis (HP:0000704) | 3.06075459 |
| 36 | Meningitis (HP:0001287) | 3.00317390 |
| 37 | Oral leukoplakia (HP:0002745) | 2.98665700 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.95521536 |
| 39 | Hypochromic anemia (HP:0001931) | 2.93343831 |
| 40 | IgM deficiency (HP:0002850) | 2.86884413 |
| 41 | Abnormality of the thoracic spine (HP:0100711) | 2.84792819 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.83497647 |
| 43 | Papilledema (HP:0001085) | 2.82005119 |
| 44 | Ureteral obstruction (HP:0006000) | 2.80134968 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.78491116 |
| 46 | Granulocytopenia (HP:0001913) | 2.78466774 |
| 47 | Eosinophilia (HP:0001880) | 2.76811186 |
| 48 | Thoracic kyphosis (HP:0002942) | 2.73640890 |
| 49 | Hemoptysis (HP:0002105) | 2.66906841 |
| 50 | Vitreoretinal degeneration (HP:0000655) | 2.66413876 |
| 51 | Petechiae (HP:0000967) | 2.63659929 |
| 52 | Paralysis (HP:0003470) | 2.60745820 |
| 53 | Abnormality of B cell number (HP:0010975) | 2.59500018 |
| 54 | B lymphocytopenia (HP:0010976) | 2.59500018 |
| 55 | Macrocytic anemia (HP:0001972) | 2.56439402 |
| 56 | Hepatic necrosis (HP:0002605) | 2.53980394 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.53396562 |
| 58 | Gangrene (HP:0100758) | 2.51093531 |
| 59 | Abnormality of the pleura (HP:0002103) | 2.46372432 |
| 60 | Stomatitis (HP:0010280) | 2.42918767 |
| 61 | Sepsis (HP:0100806) | 2.40209190 |
| 62 | Loss of speech (HP:0002371) | 2.39565211 |
| 63 | J-shaped sella turcica (HP:0002680) | 2.39238710 |
| 64 | Gingivitis (HP:0000230) | 2.35886306 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.35351588 |
| 66 | Epistaxis (HP:0000421) | 2.34820107 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.34688576 |
| 68 | Poikiloderma (HP:0001029) | 2.34118101 |
| 69 | Birth length less than 3rd percentile (HP:0003561) | 2.33783347 |
| 70 | Pallor (HP:0000980) | 2.30952475 |
| 71 | Abnormality of iron homeostasis (HP:0011031) | 2.30039833 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.29552423 |
| 73 | Severe visual impairment (HP:0001141) | 2.27466438 |
| 74 | Multiple enchondromatosis (HP:0005701) | 2.27004971 |
| 75 | Microcytic anemia (HP:0001935) | 2.26990186 |
| 76 | Annular pancreas (HP:0001734) | 2.26944743 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.26486128 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.26334338 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.26199030 |
| 80 | Paresthesia (HP:0003401) | 2.24476052 |
| 81 | Poikilocytosis (HP:0004447) | 2.23654059 |
| 82 | Abnormal platelet function (HP:0011869) | 2.23580817 |
| 83 | Impaired platelet aggregation (HP:0003540) | 2.23580817 |
| 84 | Recurrent skin infections (HP:0001581) | 2.23564698 |
| 85 | Generalized hyperpigmentation (HP:0007440) | 2.23241223 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20943880 |
| 87 | Agnosia (HP:0010524) | 2.20151123 |
| 88 | Increased hepatocellular lipid droplets (HP:0006565) | 2.20076733 |
| 89 | Pancytopenia (HP:0001876) | 2.18844568 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18404215 |
| 91 | Abnormality of male internal genitalia (HP:0000022) | 2.18283433 |
| 92 | Cutaneous photosensitivity (HP:0000992) | 2.18129640 |
| 93 | Abnormality of the lumbar spine (HP:0100712) | 2.16855153 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 2.16117925 |
| 95 | Neutropenia (HP:0001875) | 2.15142625 |
| 96 | Poor head control (HP:0002421) | 2.14719903 |
| 97 | Microvesicular hepatic steatosis (HP:0001414) | 2.14082705 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.12783243 |
| 99 | Exertional dyspnea (HP:0002875) | 2.12610922 |
| 100 | Vasculitis (HP:0002633) | 2.12557646 |
| 101 | Thrombophlebitis (HP:0004418) | 2.12251843 |
| 102 | Agammaglobulinemia (HP:0004432) | 2.11892934 |
| 103 | Increased serum ferritin (HP:0003281) | 2.11804468 |
| 104 | Cellulitis (HP:0100658) | 2.11503223 |
| 105 | Progressive microcephaly (HP:0000253) | 2.06743861 |
| 106 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06624811 |
| 107 | Amaurosis fugax (HP:0100576) | 2.04626563 |
| 108 | Ocular albinism (HP:0001107) | 2.02014063 |
| 109 | Osteomyelitis (HP:0002754) | 2.01965522 |
| 110 | Skin rash (HP:0000988) | 1.98374864 |
| 111 | Restrictive lung disease (HP:0002091) | 1.98149825 |
| 112 | Microretrognathia (HP:0000308) | 1.98092601 |
| 113 | Bone marrow hypocellularity (HP:0005528) | 1.97984978 |
| 114 | Increased intramyocellular lipid droplets (HP:0012240) | 1.97565067 |
| 115 | Urticaria (HP:0001025) | 1.97407552 |
| 116 | Skin ulcer (HP:0200042) | 1.96877701 |
| 117 | Hypoplasia of the thymus (HP:0000778) | 1.96802814 |
| 118 | Porencephaly (HP:0002132) | 1.92633163 |
| 119 | Premature graying of hair (HP:0002216) | 1.92327637 |
| 120 | Recurrent viral infections (HP:0004429) | 1.91467229 |
| 121 | 11 pairs of ribs (HP:0000878) | 1.90779791 |
| 122 | Gingival bleeding (HP:0000225) | 1.90520825 |
| 123 | Spinal canal stenosis (HP:0003416) | 1.90171947 |
| 124 | Abnormality of eosinophils (HP:0001879) | 1.89336182 |
| 125 | Prostate neoplasm (HP:0100787) | 1.88824722 |
| 126 | Progressive muscle weakness (HP:0003323) | 1.88769664 |
| 127 | Abnormality of the columella (HP:0009929) | 1.87353345 |
| 128 | Increased muscle lipid content (HP:0009058) | 1.87204234 |
| 129 | Arterial thrombosis (HP:0004420) | 1.86329919 |
| 130 | Myelodysplasia (HP:0002863) | 1.85830425 |
| 131 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.85256009 |
| 132 | Abnormality of macrophages (HP:0004311) | 1.85115254 |
| 133 | Pustule (HP:0200039) | 1.84590206 |
| 134 | Glomerulopathy (HP:0100820) | 1.84029630 |
| 135 | Acute myeloid leukemia (HP:0004808) | 1.83015670 |
| 136 | Pulmonary embolism (HP:0002204) | 1.82200609 |
| 137 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81026120 |
| 138 | Polyneuropathy (HP:0001271) | 1.80994080 |
| 139 | Vacuolated lymphocytes (HP:0001922) | 1.80298821 |
| 140 | Iris hypopigmentation (HP:0007730) | 1.80196504 |
| 141 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79404356 |
| 142 | Rough bone trabeculation (HP:0100670) | 1.79137830 |
| 143 | Increased serum lactate (HP:0002151) | 1.78789362 |
| 144 | Albinism (HP:0001022) | 1.78721209 |
| 145 | Leukocytosis (HP:0001974) | 1.78507558 |
| 146 | Abnormal hemoglobin (HP:0011902) | 1.77907771 |
| 147 | Abnormality of the pericardium (HP:0001697) | 1.77284078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK3 | 5.40557527 |
| 2 | STK16 | 4.90627316 |
| 3 | WEE1 | 2.88252749 |
| 4 | IRAK4 | 2.82424964 |
| 5 | SCYL2 | 2.81372894 |
| 6 | TEC | 2.57225271 |
| 7 | CAMK1D | 2.51236272 |
| 8 | FES | 2.49404805 |
| 9 | CDC7 | 2.35590064 |
| 10 | PIM2 | 2.31828313 |
| 11 | MAP3K12 | 2.30725434 |
| 12 | VRK1 | 2.28217106 |
| 13 | TRPM7 | 2.17145452 |
| 14 | TAOK3 | 2.15766886 |
| 15 | CAMKK2 | 2.00206087 |
| 16 | TNIK | 1.98088026 |
| 17 | TESK2 | 1.92349627 |
| 18 | BLK | 1.89826114 |
| 19 | BTK | 1.87028618 |
| 20 | CAMK1G | 1.86981177 |
| 21 | PRPF4B | 1.86428766 |
| 22 | VRK2 | 1.81421915 |
| 23 | BUB1 | 1.80433229 |
| 24 | PKN2 | 1.71141011 |
| 25 | ERN1 | 1.69788851 |
| 26 | MAP2K3 | 1.64321310 |
| 27 | SMG1 | 1.55894393 |
| 28 | EEF2K | 1.53016837 |
| 29 | CDK6 | 1.46988116 |
| 30 | MAP4K1 | 1.43860933 |
| 31 | CDK19 | 1.43061537 |
| 32 | EIF2AK1 | 1.43033373 |
| 33 | KIT | 1.40726515 |
| 34 | EIF2AK2 | 1.39311309 |
| 35 | FLT3 | 1.37812954 |
| 36 | DAPK1 | 1.30385480 |
| 37 | TESK1 | 1.26991409 |
| 38 | TNK2 | 1.26060830 |
| 39 | MKNK1 | 1.20181422 |
| 40 | CDK8 | 1.18060331 |
| 41 | MKNK2 | 1.17383450 |
| 42 | BRSK2 | 1.15661520 |
| 43 | ATR | 1.12945094 |
| 44 | NEK2 | 1.12130671 |
| 45 | TRIB3 | 1.11006298 |
| 46 | ACVR1B | 1.10868338 |
| 47 | CDK7 | 1.10470151 |
| 48 | KDR | 1.09397037 |
| 49 | RPS6KB2 | 1.07868600 |
| 50 | PAK4 | 1.05037343 |
| 51 | SYK | 1.02088649 |
| 52 | MAP3K14 | 1.01674491 |
| 53 | LRRK2 | 0.98486617 |
| 54 | RIPK4 | 0.97333731 |
| 55 | CDK12 | 0.95541494 |
| 56 | MAPK12 | 0.95227731 |
| 57 | MAP3K6 | 0.94784931 |
| 58 | NUAK1 | 0.93364000 |
| 59 | HIPK2 | 0.93339378 |
| 60 | NME2 | 0.93175043 |
| 61 | SRPK1 | 0.93011309 |
| 62 | MYLK | 0.90657771 |
| 63 | TSSK6 | 0.89643737 |
| 64 | DYRK3 | 0.88593153 |
| 65 | MAPK4 | 0.87067857 |
| 66 | BCKDK | 0.86596519 |
| 67 | CDK4 | 0.84376929 |
| 68 | IRAK3 | 0.82811436 |
| 69 | RAF1 | 0.82757660 |
| 70 | MAPKAPK3 | 0.80996197 |
| 71 | ABL2 | 0.79934677 |
| 72 | ILK | 0.78492429 |
| 73 | IKBKE | 0.77180295 |
| 74 | ITK | 0.76924320 |
| 75 | MAP3K8 | 0.76181398 |
| 76 | MAP3K11 | 0.75295509 |
| 77 | AURKB | 0.72818407 |
| 78 | LIMK1 | 0.71895216 |
| 79 | LYN | 0.71814126 |
| 80 | MAPK15 | 0.71669489 |
| 81 | ZAP70 | 0.70911719 |
| 82 | GRK6 | 0.70906767 |
| 83 | TXK | 0.69970364 |
| 84 | TYK2 | 0.68553054 |
| 85 | MARK2 | 0.63816335 |
| 86 | TLK1 | 0.63657954 |
| 87 | PIM1 | 0.63503337 |
| 88 | MAP3K7 | 0.58518637 |
| 89 | CAMKK1 | 0.58312876 |
| 90 | PLK1 | 0.57338704 |
| 91 | MOS | 0.56908532 |
| 92 | CLK1 | 0.55735273 |
| 93 | MATK | 0.55363791 |
| 94 | PLK4 | 0.55329861 |
| 95 | CSF1R | 0.54216668 |
| 96 | BRSK1 | 0.53233907 |
| 97 | MAPK11 | 0.53178610 |
| 98 | PAK1 | 0.53092192 |
| 99 | CHUK | 0.52627467 |
| 100 | PASK | 0.52439232 |
| 101 | IKBKB | 0.51830057 |
| 102 | MAP2K4 | 0.51755055 |
| 103 | GSK3A | 0.51531191 |
| 104 | CAMK1 | 0.51034953 |
| 105 | CCNB1 | 0.49437899 |
| 106 | BRD4 | 0.47224904 |
| 107 | MAP2K6 | 0.47135806 |
| 108 | CDK3 | 0.46270081 |
| 109 | PRKAA2 | 0.45980023 |
| 110 | PAK2 | 0.45887829 |
| 111 | RPS6KC1 | 0.45632620 |
| 112 | RPS6KL1 | 0.45632620 |
| 113 | RPS6KA6 | 0.45222721 |
| 114 | CSNK2A2 | 0.44732664 |
| 115 | MAPK7 | 0.44612566 |
| 116 | STK10 | 0.43170176 |
| 117 | LCK | 0.42351683 |
| 118 | CAMK4 | 0.42235619 |
| 119 | HCK | 0.42179544 |
| 120 | NEK1 | 0.41913351 |
| 121 | MAP2K2 | 0.41576356 |
| 122 | TGFBR1 | 0.40470776 |
| 123 | IRAK2 | 0.39957250 |
| 124 | JAK2 | 0.39597201 |
| 125 | RPS6KA5 | 0.39014120 |
| 126 | BMPR2 | 0.38836024 |
| 127 | TAF1 | 0.38767008 |
| 128 | RPS6KA4 | 0.38298746 |
| 129 | AURKA | 0.38205421 |
| 130 | CSNK2A1 | 0.37262924 |
| 131 | PRKCQ | 0.36635648 |
| 132 | TAOK1 | 0.36367758 |
| 133 | YES1 | 0.34743803 |
| 134 | CHEK2 | 0.33374427 |
| 135 | RPS6KB1 | 0.33049893 |
| 136 | MAP3K5 | 0.31788416 |
| 137 | TAOK2 | 0.31601638 |
| 138 | MAPKAPK5 | 0.31217462 |
| 139 | PIK3CG | 0.30643718 |
| 140 | TBK1 | 0.29959714 |
| 141 | CHEK1 | 0.29591647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.73912917 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.08289452 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.68242015 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.15933652 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.81874161 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.80102291 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.77371364 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.72034830 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.51742137 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.44250209 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.19234750 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.13497820 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.99943498 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.96957802 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.82940177 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.81816172 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.80593452 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.69445663 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.59308159 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.56184863 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.50360303 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.49191174 |
| 23 | RNA transport_Homo sapiens_hsa03013 | 1.48376964 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.44720270 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37812873 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.36816965 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35938466 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32604394 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31488906 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28617754 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25715026 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24589126 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23867067 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23014245 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20706206 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.17452286 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.13748531 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13492953 |
| 39 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 1.13275010 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.10379687 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09419431 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07805639 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01098565 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99587847 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98801117 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96947885 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87984884 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87898839 |
| 49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86244269 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83939953 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83003945 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82834429 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82266197 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.82081421 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81044549 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79184831 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78982241 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78634602 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76548630 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.74724897 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.72983273 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.72972357 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72764354 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72245305 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72138379 |
| 66 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71633833 |
| 67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68300879 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68102382 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68023190 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67552773 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67474081 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65776093 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65168828 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63981163 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62839579 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62718826 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61898334 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.61456073 |
| 79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60713013 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60628847 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59965165 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59370288 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58353476 |
| 84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58027834 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55594799 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53547159 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52723033 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.52087894 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51962126 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51175013 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50238484 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48837599 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48446282 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48252676 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46612025 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.45985015 |
| 97 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45883107 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44474369 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.44387077 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44146905 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43278544 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42493123 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41855211 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41722741 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41616764 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40475985 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40236733 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39230779 |
| 109 | * Amoebiasis_Homo sapiens_hsa05146 | 0.38995910 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38988368 |
| 111 | * Lysosome_Homo sapiens_hsa04142 | 0.38836794 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38797276 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37685090 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.37677138 |
| 115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37512416 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.36320568 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35809475 |
| 118 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35101154 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34969471 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34899528 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34086340 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33290317 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33015561 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32382498 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31905619 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31701811 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.31325865 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31195020 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31180506 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.31091120 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.30786576 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.30146401 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29270649 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28983298 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.28810203 |
| 136 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27267727 |
| 137 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.27040794 |
| 138 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26401601 |
| 139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25603480 |

